Back to Trades
Tardiff Daniel
Chief Scientific OfficerCIK 0002089301
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Tardiff Daniel, Chief Scientific Officer, has filed 4 SEC reports (2025–2026), all concentrated in Camp4 Therapeutics Corp (CAMP), totaling $1.6M in disclosed volume. Weighing $0 bought versus $8.3K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Aug 19 | CAMP Camp4 Therapeutics Corp | Tardiff Daniel | Chief Scientific Officer | Sell | $8.3K |
| Apr 3 | CAMP Camp4 Therapeutics Corp | Tardiff Daniel | Chief Scientific Officer | Award | $758.2K |
| Dec 22 | CAMP Camp4 Therapeutics Corp | Tardiff Daniel | Chief Scientific Officer | Award | $874.5K |
| Oct 10 | CAMP Camp4 Therapeutics Corp | Tardiff Daniel | Chief Scientific Officer | Other | $0 |
4 filings